Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poehlman, E. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poehlman, E. T.

The Journal of Nutrition Vol. 129 No. 1 January 1999, pp. 260S-263S

Special Considerations in Design of Trials with Elderly Subjects: Unexplained Weight Loss, Body Composition and Energy Expenditure1,2

Eric T. Poehlman3

Department of Medicine, College of Medicine, University of Vermont, Burlington, Vermont 05405


    ABSTRACT
Abstract
Introduction
References

Wasting and cachexia are significant problems in the elderly that increase mortality and morbidity. It is presently unclear as to the physiological mechanism underlying unexplained weight loss. We examine heart failure as a physiological model to demonstrate the importance of measuring several physiological outcome variables that have increased our understanding of wasting and cachexia in the elderly. These include the assessment of: energy expenditure, body composition, physical activity and exercise tolerance. We review recent data that has assessed energy expenditure in free-living heart failure patients using stable isotope methodology (doubly labeled water). Preliminary results show low levels of daily energy expenditure in heart failure patients due to extremely low levels of physical activity. Thus, a "hypermetabolic state" in free-living heart failure patients is not supported by these findings. The low level of physical activity is likely a consequence of their reduced exercise capacity and contributes to their skeletal muscle atrophy. This concept is support by the relationship between peak VO2 and muscle mass (r = 0.92; P < 0.01), as measured from dual energy x-ray absorptiometry. An understanding of the physiological factors influencing energy dysregulation and low exercise capacity may help guide future therapeutic interventions to restore energy balance and increase functional independence in patients with chronic heart failure.

KEY WORDS: body composition · energy expenditure · wasting · cachexia · heart failure


    INTRODUCTION
Abstract
Introduction
References

The intent of this short paper is to briefly highlight the importance of accurately measuring energy expenditure, body composition and exercise capacity as important endpoints in the assessment and understanding of wasting and cachexia in elderly persons. It is known that fluctuations in energy balance occur through alterations in energy intake or energy expenditure (Poehlman 1992). The balance between energy intake and expenditure ultimately determines body energy stores. Thus, unexplained weight loss, the erosion of muscle mass and decline in functional independence ultimately must have a physiological basis rooted in an energy imbalance caused by a low energy intake, an abnormally high level of energy expenditure or a combination of both. Recently, methodological advances to assess energy expenditure, body composition and physical activity have increased our understanding regarding mechanisms related to wasting and cachexia in elderly. A thorough physiological understanding of the causes of wasting is important if successful treatments are to be developed in an attempt to reverse catabolic states in the elderly.

We specifically highlight congestive heart failure to examine the physiological basis underlying cachexia and wasting. However, the tools and methodologies involved in the assessment of energy expenditure, body composition and physical activity are applicable and adaptable to the understanding of wasting and loss of physical function in other cachectic diseases such as Alzheimer's Disease (Donaldson et al. 1996, Poehlman et al. 1997) and Parkinson's disease (Toth et al. 1997a).

    HEART FAILURE AND WASTING

Heart failure is an increasingly important clinical problem, with the highest prevalence being seen in the elderly (Parmley 1989). The incidence of heart failure increases 50-fold between the ages of 40 to 60 years. At a time when mortality from coronary disease is decreasing, the incidence and prevalence of heart failure are increasing (Parmley 1989). Heart failure is now the most common hospital discharge diagnosis for those over age of 65, accounting for millions of hospital admissions each year. The unexplained loss of body weight and muscle mass are hallmark clinical features of end-stage congestive heart failure (Pittman and Cohen 1964). Weight loss may lead to cardiac atrophy and further decompensation (Abel et al. 1979). Moreover, weight loss is associated with increased mortality.

Some patients with chronic heart failure suffer generalized wasting referred to as "cardiac cachexia." Cardiac cachexia can be debilitating, leading eventually to extreme weight loss, skeletal muscle wasting, impaired mobility, as well as being associated with a poor prognosis and further deterioration in cardiac and overall function (Pittman and Cohen 1964). Many factors are likely to be involved in the pathogenesis of cardiac cachexia. For example, reduced blood flow to the limbs may deprive tissues of the necessary substrates for normal protein turnover and growth (Wilson et al. 1984). The immobility of patients who are breathless and have effort intolerance may result in disuse atrophy and deconditioning, which contribute to muscle wasting through reduced skeletal muscle protein synthesis (Gibson et al. 1987). Anorexia as a result of hepatic congestion, hypoxia, or drug toxicity, together with delayed emptying and hypomotility of the gut may cause impaired assimilation of nutrients (Berkowitz et al. 1963), resulting in an energy supply too small to maintain adequate tissue growth.

    HEART FAILURE AND ENERGY EXPENDITURE

Although many factors are likely to be involved in the pathogenesis of wasting, weight loss must ultimately be the consequence of a negative energy imbalance. Energy balance is defined as energy intake minus energy expenditure. Daily energy expenditure is comprised of several components which include: (1) resting metabolic rate, (2) the thermic effect of meals, and (3) physical activity (Poehlman 1993). The relative importance of these components in the wasting syndrome associated with heart failure is unknown.

A high resting metabolic rate has been considered one contributing factor to the negative energy imbalance and weight loss in heart failure patients. We (Poehlman et al. 1994) and others (Riley et al. 1991) showed a higher resting metabolic rate (oslash 18%; 283 kcal per day) in class III and IV heart failure patients compared to age-matched healthy individuals. Moreover, we showed that resting metabolic rate increased with severity of symptoms in heart failure (Obisesan et al. 1996). Because resting metabolic rate is a large component of daily energy expenditure (Poehlman 1993), elevations in this component may be associated with the negative energy imbalance and cachexia in heart failure patients. Although the mechanism for the higher resting metabolic rate in heart failure patients is unknown, several metabolic pathways should be considered. Increased myocardial oxygen consumption, as well as the increased metabolic cost of breathing may be contributory (Pittman and Cohen 1964). Circulating levels of tumor necrosis factor are higher in cachectic heart failure patients (Levine et al. 1990), but their relation to alterations in resting metabolic rate remains speculative. A possible explanation is elevated sympathetic nervous system activity, which is typically observed in heart failure patients, especially in the advanced stages (Davis et al. 1988). We have shown that resting metabolic rate increases in relation to increments in the rate of norepinephrine appearance into circulation (Poehlman and Danforth 1991).

Although resting metabolic rate is an important determinant of daily energy expenditure, the true determinant of energy balance is total daily energy expenditure. The doubly labeled water technique is a unique tool for measurement of free-living total daily energy expenditure in free-living patients that does not interfere with habitual daily activity. Briefly, this method is based on the difference in the rates of turnover of 2H2O and H218O in body water, which is used to estimate CO2 production rate and hence the rate of daily energy expenditure. This method uses stable isotope methodology and reliably measures long-term energy expenditure (2-3 weeks). The availability of this methodology makes is feasible to test the hypothesis that high levels of daily energy expenditure are related to the progression of cachexia in free-living individuals.

We recently tested the hypothesis that daily energy expenditure is elevated in heart failure patients (Toth et al. 1997b). Twelve cachectic patients (age, 73 ± 6 yr; weight loss = 15 ± 6 kg), 13 noncachectic patients (age 67 ± 5 yr) and 50 healthy elderly controls (age = 69 ± 6 yr) were studied. Daily energy expenditure and its components were measured using doubly labeled water and indirect calorimetry and body composition by dual energy x-ray absorptiometry. Table 1 shows the physical characteristics of cachectic, noncachectic and healthy control groups. Body mass index was lower (P < 0.05) in cachectic patients compared with noncachectic patients and healthy controls. Cachectic patients weighed less than the other groups due to a lower quantity of fat mass and fat-free mass (all P < 0.01).

 
View this table:
[in this window] [in a new window]
 
Table 1. Physical characteristics of cachectic and noncachectic heart failure patients and healthy controls

Table 2 shows measured and adjusted energy expenditure and energy intake data for the groups of subjects. Measured daily energy expenditure was lower (P < 0.05) in cachectic patients compared with the noncachectic and healthy control groups. Lower daily energy expenditure persisted in cachectic patients after statistical control for fat-free mass (P < 0.05). Differences in daily energy expenditure were primarily due to lower (P < 0.05) free-living physical activity energy expenditure in cachectic and noncachectic patients compared with healthy controls. After statistical adjustment for fat-free mass, resting energy expenditure was similar between cachectic patients and healthy controls, although a trend (P < 0.09) toward an elevated resting energy expenditure was found in noncachectic patients compared with cachectic patients and healthy controls. Reported energy intake did not differ among groups.

 
View this table:
[in this window] [in a new window]
 
Table 2. Daily energy expenditure, its components and energy intake in cachectic and noncachectic heart failure patients and healthy controls

These findings argue against an elevated energy expenditure in cachectic heart failure patients. In fact, cachectic patients had lower daily energy expenditure compared with noncachectic patients and healthy controls. Differences in daily energy expenditure were primarily due to differences in physical activity energy expenditure (Table 2). Physical activity energy expenditure was 459 and 312 kcal/day lower in cachectic and noncachectic patients, respectively, compared with healthy controls. These results underscore the importance of physical activity as a determinant of daily energy expenditure and demonstrate the need to accurately measure daily energy expenditure and its components in free-living heart failure patients before drawing conclusions about the presence or absence of a hypermetabolic state. Moreover, these initial studies suggest that a more thorough understanding of the physiological mechanisms understanding the regulation of food intake in heart failure may be an interesting area for future research.

Decreased physical activity may contribute to skeletal muscle atrophy and exercise intolerance in heart failure patients (Mancini et al. 1992; Toth et al. 1997c). Elevated rates of myofibrillar protein breakdown have been identified as a contributing factor to skeletal muscle atrophy in heart failure patients (Morrison et al. 1988). Reduced peak oxygen consumption (peak VO2) is a hallmark of chronic heart failure. Skeletal muscle atrophy may contribute to reduced peak VO2 by reducing the quantity of tissue available to utilize oxygen during exercise. We recently found a strong correlation (r = 0.91; Fig. 1) between peak VO2 and skeletal muscle mass in heart failure patients, suggesting that skeletal muscle atrophy contributes to low peak VO2, whereas this relationship was less robust in healthy elderly (0.34; P < 0.05; Toth et al. 1997c). Reduced skeletal muscle blood flow during exercise (Wilson et al. 1984) may partially explain the strong dependence of peak VO2 on skeletal muscle mass in heart failure patients. Reduced oxygen delivery to exercising skeletal muscles necessitates an increase in oxygen extraction by skeletal muscle to sustain exercise at a given workload. Increased oxygen extraction depends on both the quantity and oxidative capacity of skeletal muscle. Thus, a reduction in skeletal muscle mass or oxidative capacity would decease peak VO2 in heart failure patients. However, the degree of cardiac dysfunction and reduced oxidative capacity of skeletal muscle (Minotti et al. 1991) are also likely contributors. Although it is presently unclear whether alterations in protein kinetics are a consequence of physical inactivity, it is possible that therapeutic interventions designed to increase physical activity, such as exercise training, may preserve skeletal muscle mass by increasing myofibrillar protein synthesis (Yarasheski et al. 1993).


View larger version (13K):
[in this window]
[in a new window]
 
Fig 1. Relationship between peak oxygen consumption (VO2) and total skeletal muscle mass in heart failure patients and healthy controls. The correlation between peak VO2 and total skeletal muscle mass was significantly stronger (P < 0.01) in heart failure than in controls, as assessed by Fisher's z test. (From Toth et al. 1997).

Because no evidence for an elevated daily energy expenditure in cachectic patients was found, we suggest that reduced energy intake accounts for the weight loss in heart failure patients. Although estimates of energy intake in this study do not substantiate this hypothesis, the inaccuracy of self-reported intake diaries (Goran and Poehlman 1992) precludes a thorough testing of this hypothesis. Several factors, including abdominal pain and distension, gastrointestinal hypomotility, and delayed gastric emptying, have been suggested to contribute to anorexia in heart failure patients (Pittman and Cohen 1964). Further studies that covertly monitor food intake in heart failure patients in response to perturbations in energy balance are needed to examine the regulation of energy intake.

    SUMMARY

Several important variables have been identified to measure when designing clinical trials for the treatment of secondary wasting and cachexia in the elderly. We used heart failure as a physiological model to stress the importance of measuring energy expenditure, body composition and physical activity. The measurement of these interrelated factors provides insight into the wasting process and a more sophisticated understanding of the significance of energy dysregulation, deleterious changes in body composition and exercise intolerance to the wasting process in healthy and diseased elderly.

    FOOTNOTES
1   Presented at the workshop entitled: "Clinical Trials for the Treatment of Secondary Wasting and Cachexia: Selection of Appropriate Endpoints," May 22-23, 1997, Bethesda, MD. The workshop was sponsored by the Food and Drug Administration, Office of AIDS Research, National Cancer Institute, National Institute of Mental Health, Bristol-Meyers Squibb, Abbott Laboratories, Serono Laboratories, Inc., American Institute for Cancer Research, Roxane Laboratories, National Institute of Drug Abuse, SmithKline Beecham, National Institute of Aging, Eli Lilly Company and the American Society for Nutritional Sciences. Workshop proceedings are published as a supplement to The Journal of Nutrition. Guest Editors for this supplement publication were D. J. Raiten and J. M. Talbot, Life Sciences Research Office, American Society for Nutritional Sciences, Bethesda, MD.
2   This work was supported by the National Institute of Aging (AG-00564, AG-07857 and DK-52754), the General Clinical Research Center at the University of Vermont (RR-109) and the Claude Pepper Center at the University of Maryland at Baltimore.
3   Address correspondence to: Eric T. Poehlman, Department of Medicine, B-215 Given Building, University of Vermont, Burlington, VT 05405.

    LITERATURE CITED
Abstract
Introduction
References

0022-3166/99 $3.00 ©1999 American Society for Nutritional Sciences



This article has been cited by other articles:


Home page
Nutr Clin PractHome page
S. P. Dunn, B. Bleske, M. Dorsch, T. Macaulay, B. Van Tassell, and O. Vardeny
Nutrition and Heart Failure: Impact of Drug Therapies and Management Strategies
Nutr Clin Pract, February 1, 2009; 24(1): 60 - 75.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poehlman, E. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poehlman, E. T.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 1999 by American Society for Nutrition